Targeted therapies for triple-negative breast cancer

Triple-negative breast cancer (TNBC), a heterogeneous and complex disease entity, lacks targeted therapies due to the absence of common therapeutic targetable features that exist in other types of breast cancer (BC). TNBC patients generally respond very well to standard chemotherapy, but when TNBC r...

Full description

Bibliographic Details
Main Author: Sousa, Márcio Filipe Magalhães de (author)
Format: masterThesis
Language:eng
Published: 2020
Subjects:
Triple negative breast cancer
Synthetic lethality
Hypoxia
Angiogenesis
Antiangiogenic therapies
Resistance and senescence
Online Access:http://hdl.handle.net/10773/24253
Country:Portugal
Oai:oai:ria.ua.pt:10773/24253

Internet

http://hdl.handle.net/10773/24253

Similar Items